Latest Investments News

Opyl Limited has secured three key partnerships validating its AI-driven TrialKey platform, completed a strategic review to boost AI capabilities, and strengthened its balance sheet with a $1.5 million capital raise and Bitcoin investment.

Environmental Clean Technologies Limited has secured crucial regulatory approvals for its Bacchus Marsh fertiliser facility and completed a $275K capital raise, while deferring field trials to better align with cropping cycles. The company is also undergoing significant restructuring to improve capital efficiency and focus on strategic growth.

Empire Resources has completed a significant 21-hole reverse circulation drilling campaign at its Yuinmery Project, targeting copper-gold mineralisation across multiple prospects. Assay results are pending, with the company poised to define resource potential amid ongoing exploration.

Cambium Bio has raised A$2.12 million through a fully subscribed placement led by Taiwanese institutional investor Da Jyun Capital, supporting the initiation of pivotal Phase 3 trials for its lead ophthalmology candidate.

Platina Resources reported steady progress across multiple Western Australian gold projects in the June 2025 quarter, balancing promising drill results with operational hurdles and a solid cash position.

Jatcorp Limited reported a robust 76% revenue increase in Q4 FY25, driven by strong Moroka® sales and expanded manufacturing capabilities, setting ambitious growth targets for FY26.

Altech Batteries confirms the safety and durability of its CERENERGY® sodium-nickel-chloride battery technology through rigorous testing, while its Silumina Anodes™ pilot plant in Germany achieves a 50% capacity increase. An independent DNV study endorses the technology’s promising future.

Orion Minerals reported significant cash outflows in its June 2025 quarter, with liquidity stretched and financing facilities nearly maxed out. The company is pursuing a $5.8 million capital raising to support ongoing operations following recent feasibility study completions.

Orion Minerals is advancing its Prieska Copper Zinc Mine towards production, targeting first concentrate by Christmas 2026, supported by a recent $5.8 million capital raise and ongoing project optimisation.

Alterity Therapeutics has secured U.S. FDA Fast Track designation for its drug ATH434 targeting Multiple System Atrophy, supported by promising Phase 2 clinical trial data showing slowed disease progression and a solid safety profile.

Austral Gold’s Q2 2025 report reveals a production decline at its flagship Guanaco Mine alongside rising costs, while refurbishment at its Casposo Plant advances on schedule for a second-half restart.

Magnis Energy Technologies progresses detailed engineering on its Nachu Graphite Project and moves to fast track US anode material production, while navigating ASX suspension and IM3NY bankruptcy fallout.